MiR-1247-3p Regulation of CCND1 Affects Chemoresistance in Colorectal Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Dec 31

PMID 39739897

Authors

Dequan Wang

Jielian Wang

Fei Yao

Zhufu Xie

Jianze Wu

Huiguang Chen

Qingming Wu

Affiliations

Soon will be listed here.

Abstract

The effectiveness of chemotherapy involving 5-fluorouracil and cisplatin (DDP) for the treatment of colorectal cancer (CRC) is often limited due to the emergence of drug resistance. An increasing body of research highlights the crucial role of abnormally expressed microRNAs (miR/miRNAs) in fostering drug resistance in various types of cancer. The present study was the first to explore the potential roles and mechanisms of the small non-coding RNA miR-1247-3p in CRC, particularly its association with DDP resistance in CRC. The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. By contrast, there was a marked increase in the expression of cyclin D1 (CCND1), a known target gene of miR-1247-3p that is negatively regulated by this miRNA. By modulating CCND1, miR-1247-3p can effectively reduce drug resistance and promote apoptosis in CRC cells, suggesting that miR-1247-3p could potentially reduce chemotherapy resistance by targeting CCND1. These results highlight the pivotal role of miR-1247-3p in reducing chemotherapy resistance through the inhibition of CCND1, providing insight into a promising therapeutic strategy for overcoming CRC resistance.

References

Wang S, Cao J, Pei L . Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis. Histol Histopathol. 2022; 38(1):99-112. DOI: 10.14670/HH-18-502. View

Chua P, Lim J, Guo T, Khanna P, Hu Q, Bay B . Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. Int J Oncol. 2018; 53(6):2579-2589. DOI: 10.3892/ijo.2018.4557. View

Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S . Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(9 Pt B):2871-2880. DOI: 10.1016/j.bbadis.2018.05.020. View

Huan L, Guo T, Wu Y, Xu L, Huang S, Xu Y . Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response. Mol Cancer. 2020; 19(1):11. PMC: 6971890. DOI: 10.1186/s12943-019-1122-z. View

Dragomir M, Mafra A, Dias S, Vasilescu C, Calin G . Using microRNA Networks to Understand Cancer. Int J Mol Sci. 2018; 19(7). PMC: 6073868. DOI: 10.3390/ijms19071871. View

Esteban-Gil A, Perez-Sanz F, Garcia-Solano J, Alburquerque-Gonzalez B, Parreno-Gonzalez M, Legaz-Garcia M . ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer. Sci Data. 2019; 6(1):255. PMC: 6823353. DOI: 10.1038/s41597-019-0198-z. View

Huang C, Tsai M, Wu Y, Lee Y, Yen A, Wang C . Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR-1247-3p-modulated integrin/FAK axis. Environ Toxicol. 2023; 39(4):2077-2085. DOI: 10.1002/tox.24087. View

Ding H, Wang Y, Zhang H . CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma. J Pharmacol Sci. 2020; 143(3):219-225. DOI: 10.1016/j.jphs.2020.04.006. View

Shi Q, Li Y, Li S, Jin L, Lai H, Wu Y . LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020; 11(1):5513. PMC: 7608661. DOI: 10.1038/s41467-020-19349-w. View

10.

Park J, Kim Y, Park E, Lee S, Kim H, Kim A . Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer. Cancer Sci. 2019; 110(9):2834-2845. PMC: 6726705. DOI: 10.1111/cas.14124. View

11.

Wang J, Su W, Zhang T, Zhang S, Lei H, Ma F . Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2023; 14(4):244. PMC: 10079974. DOI: 10.1038/s41419-023-05763-7. View

12.

Dragomir M, Knutsen E, Calin G . Classical and noncanonical functions of miRNAs in cancers. Trends Genet. 2021; 38(4):379-394. DOI: 10.1016/j.tig.2021.10.002. View

13.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

14.

Li Z, Tian J, Chu Y, Zhu H, Wang J, Huang J . Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells. J Bone Oncol. 2023; 43:100512. PMC: 10665705. DOI: 10.1016/j.jbo.2023.100512. View

15.

Tian Y, Chen Z, Wu P, Zhang D, Ma Y, Liu X . MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer. Adv Sci (Weinh). 2023; 10(12):e2204819. PMC: 10131819. DOI: 10.1002/advs.202204819. View

16.

Lin J, Zheng X, Tian X, Guan J, Shi H . miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance. J Cancer. 2022; 13(7):2040-2049. PMC: 9066213. DOI: 10.7150/jca.65167. View

17.

Dai C, Dai S, Gao Y, Yan T, Zhou Q, Liu S . Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer. Epigenetics. 2023; 18(1):2175565. PMC: 10026884. DOI: 10.1080/15592294.2023.2175565. View

18.

Fang T, Lv H, Lv G, Li T, Wang C, Han Q . Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018; 9(1):191. PMC: 5768693. DOI: 10.1038/s41467-017-02583-0. View

19.

El Menshawy N, El Marghany A, Sarhan M, Aladle D . Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity. Asian Pac J Cancer Prev. 2020; 21(10):2941-2947. PMC: 7798150. DOI: 10.31557/APJCP.2020.21.10.2941. View

20.

Pothuraju R, Rachagani S, Krishn S, Chaudhary S, Nimmakayala R, Siddiqui J . Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020; 19(1):37. PMC: 7041280. DOI: 10.1186/s12943-020-01156-y. View